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~ Quantitative Oobul~mlne~ Stress Echocardiography 
Utilizing Doppler Tissue Imaging 
Hector L Fontanet, John A. PuteO, Mifct~ll G. Davis, Ma~ Lockeby, 
Use Thannlkary, OOU91as D, Scho~en. DMsion of Cardiology, University. of 
South Florida, Tampa, F~or~da 
Detection of myoo,.~diai ischemla (MIS) by Dobutemine Stress Echo (DSE) 
is limited by qualitative, observer dependent Shah/sis Doppler tissue imegt~g 
(DTI) (Acuson XPc 128) can measure myocardial velocities during DSE and 
may be useful to quantify wall motion abnormalities. Themtom, the purpose 
of this study Is to c~temline whether pulsed wave DTI can detect and quantity 
stress Induced MIS by changes in MV. Methods: 24 i~tle~ts had DSE with 
DTI. Systolic velociflcs (SV) of the loferior(IW) and antedo~' walls(AWl were 
examined. 16 patients had a normal response and 8 had inducible Ischemla. 
The abnormal group had arlgiogt~aphlc evidence of coronary disease (C~Et) 
(RCA or LAD > 70%). Results: There was a signglcant dose depand~nt 
increase in SV in the normal group: tW 0.064 to 0.133 m/s (p < 0,0001); AW 
0.05-,0.10 r~s (p < 0.001). Compared to normats, patients with CAD had 
lower resting SV and a blunted increase during DSE: IW 0.043 to 0.069 m/s 
(p < 0,0001); AW 0,04-0,06 m/s (p < 0,01) (figure). 
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Co~[~sions: Patients with CAD have impaired augmontatlon of systolic 
myocardial velocities during DSE. Thus, DTI may be useful in the quantitative 
anaiysis of slreSS induced myocarolai ischemla. 
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~ A  Ho,,ml inhibitor of Plssm|ne~ert Acttvato~ 
inhibltsr-1, T-686, Modulates Development of 
Atherosclerosls in Vlvo In Rabbits 
Beds VInegradsky, Stephen P, Bell, Hitoshi Okada, Amy S, Guaia, 
DagnijaThomton, Satosh~ FuJit, Washington Unh, arsily, St. Lou;s, Me; 
University of Vermont, Burlington, VT 
We have previously shown that plasmlnegen activator inhibitor-1 (PAl-I), 
the major inhibitor of tissue-type plasmlnogan astivator and urokinase, is 
abundantly expressed in athorosclerotlc vascular wall. To dotsrmine the role 
of PAI-I In vascular wail, we have used a novel inhibitor of PAl-l, (3E, 4E)-3- 
benzyltdene-4-(3,4,5-trlmsthoxy-benzylideno)-pyrrolldlne-2,5-dione ('r-686). 
In rabbits with aDdle atherosslerosls induced by hypercholesterolemia and 
implantation of indwelling plastic tubing, oral administration el T-686 (30 
mg/kg body wc~ght) for 8 weeks attenuated the Increase In Plasma PAl-1 
activity induced by vascular injury (2.7 ± 0.9 (SE) AU/ml, n = 7, vs 4.0 .~ 0.8 
AU/ml In control, n = 8) without altering blood triglycaride and cholesterol. 
Thle was accompanied by the reduction in so,lie PN-1 mRNA expression 
(relative absod:)ance PAI-1/GAR 0.21 • 0.04, n = 7 vs 0.86 ~ 0,20 in control, 
n ,= 8, p .~ 0.05, Northern) and the inhibition of development of athomsderasis 
lesions (lesion area over total addle area, 25:1= 2%, n = 8, vs 44 :t: 7% in 
control, n = 9, p < 0.05). 1"-686 prevented the accumulation of PAl-1 within the 
aortic lesions (Immunohfstoohemistry) and expansion of extmcollular matrix 
(maximal intimai thickness, 124 -4- 10 p.m, n = 8, vs 155 ~: 22 pm in control, n 
,= 9). In contrast, PAF1 mRNA expression in liver was not altered (Northern). 
ThuS, T-686 not only decreased PAl-1 synthesis atsctively in vascular Cells 
but also protected against the development of vascular lesions In rive. This 
compound may be useful in relining the role ol PAt-1 in atherothromt~Otio 
states. 
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Prothrombotlc Fec lom and Edothellal DyMuncl ion 
In Left Ventdcular Hypertrophy: ImpliP.atlons for 
Thrombogenesls and Atherogenesla 
Gregory YH Up, Andrew Blann, Peck Un Lip, Gareth Beavers. University 
Department of Medicine, City Hospital, Birmingham, England 
Hypertensive patients with left ventrlcular hypertrophy (LVH) are at high risk 
of thrombaembOlism and atherogenosis. TO investigate this further, we mea- 
sured p~asma levels of the soluble adhesion melecute P.setsctln (ELISA, 
R&D Systems; assootated v~th platetet adhesion ~.ed alhgrosclerosis), Yon 
Wi~ebra~d factoY ~vWF; ELqSA, OAKO; a marker ot eedofhaiiat dysfunction), 
fibrin D.dimer (AGEN-ELISA; an index of fibrin fumover/thrombo(Janasls), 
plasmlnegen ac~ator Inhlbttor (PAt, an index of tr~aired flbfl~olyais & In. 
creased lhromboganesls) and llbrinngen {PF; CLAUSE;) in 159 patients (74 
male; mean age 54.1 years, e.d. 1¢8) with essential hypertension, in whom 
the left ventricular mass index (LVMI) was determined using echocardiogra- 
phy. Levels were compare~ to 47 normotendve healthy controls (mean age 
55.0 years, s.d. 19.2). 
Results: 
Hypertensive Conlrols 
Mean bicmd pressure (BP) 180/101 133/81 mmHg 
P-sel~ctln (ng/ml) mad/an (IQR) 300 @ (190,480) 212 (160-3500) 
PAt {~g/ml) medlan (~QR) 31.0" |2~.5-43.1) 19.6 (10.9--31.0) 
D-dlmer(nglmi)medlan(IOR) 250" (190,~0) IS8 (100-231) 
vWF (iU/d|} mean (s.d.) 115"* (30} 07 (27,) 
fibrinogen (g/I) mean (s.d.) 3.39 + if.02) 2.9~ (0.49) 
@p = 0.016, *p < e.oool, "*t-test; p = 0,0002, +p - 0,001 
Patients with LVH (defined as LVMI > 134/n~ in males or > 110 g/m ~ in 
females) had higher PF compared to those without LVH (3.51 vs 2.95 g/I; 
p = 0,0006). D-dimer levels were correlated with vWt (Spearman, r = 0.45; 
p < 0,001) and PF (r = 0,20; p = 0.035) levels. PF levels were correlated 
with systolic and diastolic BPs (both r = 0,40; p < 0.001), LVMI (r = 0.23; 
p = 0.018), left atrial size (r = 0,32, p =~ 0,002), P-seleclin (r ,= 0.17; p = 
0,05) e.d vWF {r = 0.34; p< 0,001). This study suggests that hypertensives 
have h4gh PF levels, thmmbagenasis and impaired fibd~otysts ~as indioated 
by high D-direst and PAl levels), plalelet dysfunction (raised P.salectin) and 
endothelial dysfunction (high vWF). The high PF levels were related to ape, 
LVMI (and LVH) and left atrial size. These factors may act synergistically to 
increase the dsk of thmmbogenosis and atherosclerosls and may explain the 
high dsk of vascular disease in hypertensives with LVH. 
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~ R o l e  the Procoagulant Activity on of Factor XaNa in 
Balloon.Injured Artsdes 
Giorgio Ghigliotti 1 Dana R. Abendschain, Christopher M. Spaidel, Paul 
R. Eiset~berg. I Univers~y of Genoa, Italy; Washington University School or 
Medicine St. Louis, MO 
We and others have shown that balloon-induced deep arterial injury exposes 
tissue factor (TF), which initiates thrombosis. However, the contributions of 
th~mbin and XaNa activity elaborated and bound at the site of in|uq/to 
the progression of thrombosis is not known, To determine their relative role, 
deep injury to the abdominal aorta was induced by oveflnt~ation of a 4F 
Fegady calheter tn 29 anesthetized rabbits. As a control group, eight other 
rabbits underwent the surgical procedures, but without balloon ovednflalion. 
Aortae were perfused in situ with phosphate-buffered saline to prevent In- 
travascular cloffing, excised and extensively washed in buffer. Injured ~.ortic 
segments were incubated for 30 rain with reca1¢itied plasma depleted of 
vifamin K-dependent factors by edsorbtion with barium ohPodd9 (Be plasma) 
to characterize thmmbin activity, followed by incubation with Ba plasma con- 
taining 0.9 pM prothrombio to characterize Xa/Va activity. Concentrations of 
tibfinopeptide A (FPA) were measured in the incubat~:l plasma as a marker 
of thrombin-mediated flbdn formation. Uninjured segments did not induce 
significant increases in FPA in =Ja plasma with (26 :E 20 ng/ml, mean 4- SO) 
or without (9 '4- S ng/ml) added prothmmbln. Injured segments also did not 
induce fibrin formation in Ba plasma (19 :t: 13 ng/ml), consistent with little 
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or no bound thrombin activity at the In~ry site. However, injured segments 
induced significant elaboration of FPA in Ba plasma containing prothrombin 
(203 4- 186 ng/ml, p <~ 0.01 vs Ba plasma alone), consistent w~th XaNa 
complex bound to the site of injur~, Thus, the factor XaNa complex rapidly 
associates at the site of deep arterial tnluty, presumabiy on platelets, and is 
the principle determinant of persistent procoagulant activi~ on the luminal 
surface. 
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~ De~rassed Platelet end Neutrophil Oeposition 
De~pite Perslsttent Ymmconstrletive Response 
During L.Arglnine infusion Following Balloon 
AngloplaSly 
Daniel H~bert, Jules Y.T, Lain, Y~,nnick Beaulieu. Montreal Heart institute, 
Montreal, Quebec, Canada 
Reduction of endothelial cell and vascular nllric oxide (NO} synthesis and re- 
lease can be induced by mechanical injury to the vessel wall, Diminished NO 
may contribute to the increased platolet (PLT) and nsutrophil (PMN) depo- 
sition and the distal vesoconstrictive response following balloon angioplasty. 
Whether admfnistrallen of L-arginine {1,5 g bolus + 10 mg/ktymin infusion), 
the NO precursor, may be able to reverse thee ~,9.~, w~ $~..,dled. Nor- 
mal Yorkshire pigs unden~ent carotid arterial injury by balloon angioplasty 
(5 Inflations of 30 sen at 6 aim, with 1 mfn interval) prior to administration of 
L-arginine (n = g) for a period of 15 min and compared to pigs who were ad- 
ministered saline (control; n = 6). Impedance platelat aggregation induced by 
ADP was significantly r6duced during L-arginine infusion. AUtologeus Cr s~ -
laballnd Idatelet and In ~ *labelled nsutmphil deposition at the site of deep 
a~edal in[ury, and the degree of angiegrephic vasoconstriction at the site of 
endothelial denudation induced by the tapering distal end of the balloon, are 
shown below (mean ± SEM): 
Group PLT deposition PMN deposition Vasoconstriction 
(x 108/¢m ~) (x 103/¢nT ~') (% baseline) 
Control 44.3 ± 8.7 398.3 4  `64,1 38.0 :E 3.6 
L-a~ginine 18.9 ± 5.1 • I g6.04, 52.4" 40.8 4, 5.6 
*p < 0.05 W, o~ntml 
Thus, infusion of L-arginine influences platelat and neutrophit deposition 
at the site of c~ep artedal injury without affecting the distal vaSOconstrictive 
response induced by endothelial denudation as assessed in our pig model. 
L-arginlne may have a differential effect on circulating blood cells and [he 
vasculature. 
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~l 'he  Elevated NF~B ACtivity and MCP-1 Expression 
In Endothelial-Injured Arteries From 
QuHy~anapholssteroleml¢ Rabbits Are Prevent~l  by 
rli 
Miguel H. Prasa, Carmen Busies, M6nica Ortego, Joe6 Tufl6n, 
Marts Ruiz-Ortoga, Julio G. Puente, Jesds Egldo. Fundaci6n Jimdnez.D[az. 
U.A.M, Madrid. Spain 
Although Angletonsin II (AUglI) 5earns to participate in the patl~genesis 
ot atherosdemsis, its role in this setting remains unclear, in a model of 
endothelial damage and atberogenic diet in rabbits, we have studied the effect 
of quinepril (Q) on the artsdal nuclear faster NFkB activity and mon0cyte 
chemoattractant protein.1 (MCP-1) mRNA expression. Two days before the 
endothelial damage (day 0), anlmaJs were randomized tO no treatment (NT) 
(n = 9) or Q ( 1 mg/Kg/day) (n = 9) and were killed on day 7. On this day, 5erum 
and vas~|ar AGE activity was inhibited by > 70% and 50% respectively in 
Q vs NT group. NFkB a~ivlty (gel shift assay) was increased in the ariedes 
of NT animals vs controls, and Q markedly reduced this est~ty. MCP-1 
expression (RT-PCR) was also elevated in the arteries of biT vs Q (6.3 :t: 1,2 
vs 3.4 ± 1A a.u; p < 0.04). The reduction in MCP-1 mRNA i~uced by Q 
paralleled that of intimal infiltration of macropheges (immunohistochomtstW). 
Since macropheges are the main celts impti~,ted in the incre~ of MCP-1 
obeerved in atheresclerotic lesions, we studied the effect of Aug tl on NFkB 
activity and MCP-1 expression on the monocytic ell line U937. Ang II (10 "s 
M) InP..reased NFkB activity and MCP-I expression (3-told; Northern blot), 
being maximal at 2 h arid 6 h of i~ubation, respectively. Preincubation of 
ce~ts w~ the NFk~ inhibitor p,/wolidins dlthiocarbamate abolished the Angll- 
induced MCP-1 expression. Our results show that Angif increases the MCP-1 
expression through th~.induc~on t)f NFkB and therefore may ~tdicipate in 
the cell recruitment to tits injured vessel wall. ACE inhibitors might have a 
benefldal effect in the eadlast phases oi atherosclarosls by modulating those 
Angll effects. 
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~ D.~emntla! Expression o! Collagen Subtypes Ill and 
IV in Numan Vein Graft Atherosclerosis 
Stephen M. Denning, Keith M. Channen, Kevtn G. Peters, Brian H. Annex. 
Division of Cardiology, Duke Unive~Jity Medical Center, Dumam, NC 
Collagens compdse the major mass of atherosciaratic lesions and accumu. 
late in models of vein graft (VG) ~therosclerosts. However, collagens are a 
family of genetically distinct proteins with dilterent physiologic roles and po- 
tentially different mechanisms of regulation. We used Immunohistochemistry 
to study the expression cf type III (fibdllar) collagen and type IV (basement 
membrane) collagen in 18 control saphenoue veio (CSV) segments and in 
53 freshly excised VG ssgmer~ from 31 patients. In CSV, collagen III and 
IV were present in the intlma in only 2 (t 1=/,) of 18 segments compared to 35 
(70%) of 61 segments fur collagen III and 46 (92%) of 51 segments for colla- 
gen IV. Inttmal collagen III and IV expression tended to Increase when vessel 
segments were classified as mild (n ~ 21, 43% vs 67%), moderate (n = 11, 
73% vs 100°/,) and severely (n = 21, 90% vs 100%) diseased. Also, different 
apatial patterns of collagen III and IV expression v,'ere frequently observed 
on sedal sections. Collagen III predominated in regions of fibrous caps while 
type IV was diffusely present in the Intima and often was associated with 
areas of neovascolarizatlen. In conoluslon, thasa studies provide the first 
description of collagen subtype xpression in human VG ahheroscteresis and 
suggest hat collagen subtypes may be differentially regulated in this aisease 
process. Changes in collagen expression may provide insights into POtential 
mechanisms involved in VG athorescleresis. 
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~ A  New Method for F Wave Signal Averaging 
Cheng Xiao Miug, Nashe E. North, Ronald Oliver, John H. McAnutty, Blair 
D. Halperin, Mmritt H. Rak't. Oregon Hea#h Sciences University, Poland 
OR 
A new method for accurate temporal alignment and template matching de- 
signed for P wave averaging is described. 
Methods: Signal averaging ~ performed using waveforms digitized at 
2000 Hz. The template included the entire waveform of interest and was 
defined relative to the peak of the QRS. The fast Fourier transform was 
used to derive an autocorrelation wave (ACW) for the entire tetrcdats and 
a c~sscorrelation wave (CCW) from the template and each incoming beat. 
The timing of the peaks of the ACW and CCW was used to adjust temporal 
alignment correcting fur any variation in the PR interval. A new CCW was 
derived post realignment. The difference between the ACW and new CCW 
was used to determine beat acceptance. This method was ¢o~ to 
the standard correlation coefficient method by analyzing synthesized sine, 
square and tdangle waves which varied in frequency and/or amplitude, and 
surface P waves from pigs pre and post isoproterenol (ISO) infusion. 
Results: Our method resulted In rejection of syr4hosized wevefmms that 
were not identical to the template while the standa~ methed accepted waves 
that reded in frequency and amplitude from the template. ISQ infusion m- 
suited in clew moqoholnglo changes in the surface P wave and shortening 
of the PR intenral, Using the base~iue P wave temp~ts the new method re- 
~'tsd all P waves during ISO infusion while tl~ standard method continued 
tO accept many P waves for averaging resulting in a signal averaged P wave 
which varied significantly from the template. 
Conclusion: This new algorithm is mine sans'dive to changes in wavetorm 
meq~holngy compared to standan:l correlation coefficient methods and is 
espedally advantageous for P wave averaging in that it allows for adjustment 
on e beat to bee* basis for changes in the PR integral. 
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TACHY, a Computer Expert Sy~em for the 
Management of Supraventrlculer TachyP,,a~la In the 
Bck~y 
ShaoSun Waug, Jiming Xle, William J. French t Beljing Hospital, China: 
Saint John,s Cardiovascular Research Center, H~rbor-UCLA Medicat 
Center, Torra~, CA 
Doctors In training and non.cardiologist often find the management ofaupraven- 
tricular tachycardla ($VT) in the elderly difficult. An interactive computer 
exl~ert system to recommend therapies and remind ~e physician of poton- 
